News Related to Progressive Lung Damage

Related coverage linked through entity extraction aliases.

CRISPR Gene Editing Advances in Heart Failure, Cystic Fibrosis, and Cholesterol Treatment

Mar 09, 2026

Three new CRISPR-based therapies show promise for treating heart failure through mitochondrial enhancement, cystic fibrosis via lipid nanoparticle gene insertion, and elevated cholesterol with single-dose gene editing targeting ANGPTL3.

Lipid Nanoparticles Deliver Full CFTR Gene in Cystic Fibrosis Gene Therapy Advance

Feb 18, 2026

UCLA researchers developed lipid nanoparticle-based gene editing that inserts a complete CFTR gene into human airway cells, restoring up to 100% of normal channel function in cystic fibrosis laboratory models without viral vectors.